AAV CAMKII PSAM4 GlyR IRES EGFP Citations (2)

Originally described in: Ultrapotent chemogenetics for research and potential clinical applications.
Magnus CJ, Lee PH, Bonaventura J, Zemla R, Gomez JL, Ramirez MH, Hu X, Galvan A, Basu J, Michaelides M, Sternson SM Science. 2019 Mar 14. pii: science.aav5282. doi: 10.1126/science.aav5282. PubMed Journal

---

Articles Citing AAV CAMKII PSAM4 GlyR IRES EGFP

Articles
Chemogenetics with PSAM(4)-GlyR decreases excitability and epileptiform activity in epileptic hippocampus. Gonzalez-Ramos A, Berglind F, Kudlacek J, Rocha ER, Melin E, Sebastiao AM, Valente CA, Ledri M, Andersson M, Kokaia M. Gene Ther. 2025 Mar;32(2):106-120. doi: 10.1038/s41434-024-00493-7. Epub 2024 Oct 25. PubMed
Information sharing within a social network is key to behavioral flexibility-Lessons from mice tested under seminaturalistic conditions. Winiarski M, Madecka A, Yadav A, Borowska J, Wolyniak MR, Jedrzejewska-Szmek J, Kondrakiewicz L, Mankiewicz L, Chaturvedi M, Wojcik DK, Turzynski K, Puscian A, Knapska E. Sci Adv. 2025 Jan 3;11(1):eadm7255. doi: 10.1126/sciadv.adm7255. Epub 2025 Jan 3. PubMed

If you have published an article using this material, please email us at to have your article added to this page.